Last reviewed · How we verify

NCT06980662

The Effect of Laughter Yoga in Beta Thalassaemia Major Patients: a Randomised Controlled Trial

Not yet recruiting NA Last updated 20 May 2025
What this trial tests

NA trial testing laughter yoga in Beta Thalassemia Major in 60 participants. Not yet recruiting.

Timeline
1 June 2025
Primary endpoint
31 August 2025
31 August 2025

Quick facts

Lead sponsorAtaturk University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 June 2025
Primary completion31 August 2025
Estimated completion31 August 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ataturk University

Who can join

Adults 18 to 65, any sex, with Beta Thalassemia Major or Thalassemia Majors (Beta-Thalassemia Major). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to evaluate the effects of laughter yoga on Fatigue, Depression-Anxiety-Stress, Sleep quality, Haematological values and Blood transfusion number in Beta Thalassemia Major patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of laughter yoga

Trials testing the same drug.

Other recruiting trials for Beta Thalassemia Major

Currently open trials in the same condition.

Other Ataturk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06980662.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing